Clinical Studies

EXIT-CVD validates its early, mid, and late exit strategies through a portfolio of clinical studies conducted by consortium partners across Europe, Canada and U.S.A. Explore study design, recruitment status, and participating sites below.

Showing 22 of 22 studies

Planning WP4

BRIDGE-HF

Evaluates innovative treatment strategies (including mechanical circulatory support devices, regenerative therapies, and minimally invasive surgical procedures) to prevent further progression of advanced cardiovascular disease, stabilize cardiac function, and promote recovery of damaged heart and vascular tissues.

View study
Planning WP2

CSPC-CT (Comparative Validation of GE PCCT)

The study CSPC-CT, Comparative Study of Standard and Photon Counting CT in Cardiac Imaging, isa prospective clinical imaging study designed to evaluate whether Photon Counting CT (PCCT) can improve cardiac CT assessment compared with standard coronary CTangiography in patients at risk of coronary artery disease.

View study
Planning WP4

HOPE

This preclinical translational study aims to improve the preservation of donor hearts during hypothermic oxygenated machine perfusion (HOPE). Although this technology has already demonstrated the ability to substantially extend donor heart preservation, further optimization is needed to support wider clinical implementation and maximize donor heart utilization.

View study
Planning WP2

COMPASS

Pilot RCT evaluating remote postpartum blood pressure monitoring with wearable devices and a digital cardiovascular platform in women with hypertensive disorders of pregnancy.

View study
Planning WP3

FINGERPRINT-CAD

Observational study evaluating whether AI analysis of wearable ECG signals can improve prediction of periprocedural myocardial infarction in patients undergoing PCI.

View study
Planning WP4

IMPACT-MIDCAB

Evaluates innovative treatment strategies (including mechanical circulatory support devices, regenerative therapies, and minimally invasive surgical procedures) to prevent further progression of advanced cardiovascular disease, stabilize cardiac function, and promote recovery of damaged heart and vascular tissues.

View study
Planning WP2

PATHWAY-CV

Study implementing a structured smartphone app-based monitoring program with wearable devices to improve cardiovascular risk factor control after acute coronary syndrome.

View study
Planning WP2

PROMISE

Observational questionnaire-based study evaluating awareness, recognition, and patient experiences of typical and atypical myocardial infarction symptoms.

View study
Planning WP2

REMODEL-HF

Clinical validation of a wearable monitoring device, called the Heart Failure Management System (HFMS) to demonstrate improved heart failure management outcomes (hospitalizations, mortality, and biomarker improvement).

View study